Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Immunization
New immunization study findings recently were published by M. Jit and co-researchers
September 24th, 2008
" To assess the cost effectiveness of routine vaccination of 12 year old schoolgirls against human papillomavirus infection in the United Kingdom. Economic evaluation. UK. Schoolgirls aged 12 or older," scientists in London, the United Kingdom report. "Main outcome measures Costs, quality adjusted life years (QALYs), and incremental cost effectiveness ratios for a range of vaccination options. Vaccinating 12 year old schoolgirls with a quadrivalent vaccine at 80% coverage is likely to be cost effective at a willingness to pay threshold of 30 pound 000 ((sic)37 700; $59 163) per QALY gained, if the average duration of protection from the vaccine is more than 10...
Source: Vaccine Weekly (2008-09-24)
|
